Paxman Investor Relations Material
Latest events
Q2 2025
Paxman
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Paxman
Access all reports
Paxman AB is a Swedish medical device company specializing in scalp cooling systems designed to minimize hair loss in patients undergoing chemotherapy. Its primary product, the Paxman Scalp Cooling System, is used in hospitals and cancer centers globally to help reduce chemotherapy-induced alopecia. The system works by cooling the scalp, which reduces the impact of chemotherapy on hair follicles. The company is headquartered in Karlshamn, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
PAX
Country
🇸🇪 Sweden